An increasing proportion of US smokers smoke 10 cigarettes per day (CPD) or do not smoke every day, yet the health effects of low-intensity smoking are poorly understood. We identified lifelong smokers of <1 or 1-10 CPD and evaluated risk of incident cancer among 238,525 cancer-free adults, aged 59-82, in the NIH-AARP Diet and Health Study. A questionnaire administered in 2004-2005 assessed CPD during nine age-periods (<15 to 70). We estimated hazard ratios (HR) and 95% confidence intervals (CI) using multivariable-adjusted Cox proportional hazards regression with age as the underlying time metric. Of the 18,233 current smokers, (7.6%), 137 and 1,243 reported consistently smoking <1 CPD and 1-10 CPD, respectively. Relative to never smokers, current smokers who reported consistently smoking 1-10 CPD over their lifetime were 2.34 (95% CI 5 1.86-2.93) times more likely to develop smoking-related cancer. Current lifetime smokers of <1 CPD were 1.89 (95% CI 5 0.90-3.96) times more likely to develop tobacco-related cancer, although the association did not reach statistical significance. Associations were observed for lifelong smoking of 10 CPD with lung cancer (HR 5 9.65, 95% CI 5 6.93-13.43); bladder cancer (HR 5 2.22, 95% CI 5 1.22-4.05); and pancreatic cancer (HR 5 2.03, 95%CI: 1.05-3.95). Among lifelong 10 CPD smokers, former smokers had lower risks of smoking-related cancer with longer time since cessation and longer smoking duration. Lifelong <1 and 1-10 CPD smokers are at increased risk of incident cancer relative to never smokers and would benefit from cessation, providing further evidence that even low-levels of cigarette smoking cause cancer.
an increased risk of tobacco-related cancer, but these studies 14, 15 have largely been unable to distinguish those who smoked at low-intensity over their lifetime from those who smoked much more earlier in life. 16, 17 We recently found strong associations between lifelong low-intensity smoking (10 CPD) and total and causespecific mortality in the National Institutes of Health (NIH)-AARP cohort. 18 To provide further data on the health risks of low-intensity smoking, we now extend these findings to examine the incidence of smoking-related cancers among lifelong low-intensity smokers.
Material and Methods
The NIH-AARP Diet and Health Study has been previously described. 19 In 1995-1996, an initial questionnaire regarding demographics, lifestyle, diet, and medical history was mailed to approximately 3.5 million AARP members, aged 50-71, in six US states (California, Florida, New Jersey, North Carolina, and Pennsylvania) and two metropolitan areas (Atlanta, Georgia and Detroit, Michigan); 566,398 men and women successfully completed the questionnaire. In 2004-2005, the follow-up questionnaire was mailed to the remaining cohort participants to update information on medical history and lifestyle, including comprehensive assessment of lifetime cigarette smoking. The follow-up questionnaire was completed by 313,363 participants and serves as baseline for the current analysis. After excluding proxy respondents (n 5 13,392), participants with a prior cancer diagnosis (n 5 36,507), a death only record for cancer (n 5 1,366), who moved out of the cancer registry catchment area prior to follow-up (n 5 16,093), and those reporting incomplete smoking information (n 5 7,480), our analytic cohort consisted of 238,525 individuals (134,802 men and 103,723 women). The NIH-AARP Diet and Health Study was approved by the Special Studies Institutional Review Board of the National Cancer Institute. Participants were informed in a letter accompanying the baseline questionnaire and consented by completion and return of questionnaires.
Cigarette smoking and covariates
In addition to ever and current cigarette smoking, the 2004-2005 questionnaire assessed their cigarette smoking during nine age-periods (<15, 15-19, 20-24, 25-29, 30 -39, 40-49, 50-59, 60-69, 70 years) up to current age. Participants were asked to choose the category of CPD (none, <1, 1-10, 11-20, 21-30, 31-40, 41-60, and >60) which best described their smoking in each age-period. We determined age at smoking initiation and duration of smoking based on this information. We previously reported that 74% of participants who reported lifelong smoking of 10 or fewer CPD in the 2004-2005 questionnaire also reported currently smoking 10 or fewer CPD, and 24% reported smoking 11 to 20 CPD at the time of the 1995-1996 questionnaire. 18 We collapsed reported CPD categories at each age-period into five categories (<1, 1-10, 11-20, 21-30, and >30 CPD) for the analysis. Because of small numbers of most cancer cases among consistent low-intensity smokers, low-intensity smokers were defined as 10 CPD combining <1 and 1-10 CPD categories for analyses of individual smoking-related cancer sites or groups. To assess smoking over the lifetime, we considered CPD from age 20 or age-period of smoking initiation, whichever occurred later. To identify smokers who reported consistently smoking the same CPD category or who varied their smoking intensity over the lifetime, we excluded individuals who had a missing value for CPD in one or more age-periods (6,029 former and 1,593 current smokers) or who started smoking at age 60 or older (n 5 438), resulting in 230,465 participants.
Additional factors including body mass index (BMI; computed using self-reported height and weight), physical activity, familial history of cancer, history of comorbid conditions (e.g. heart attack, stroke, diabetes, and chronic obstructive pulmonary disease), and perceived general health were also re-assessed in the 2004-2005 questionnaire. Gender, race/ethnicity, highest achieved education, alcohol intake, and ever use of cigar or pipe were assessed in the initial cohort questionnaire in 1995-1996.
Outcome ascertainment
Participant addresses were updated annually in response to change of address requests and by matching cohort participants to the US Post Office National Change of Address database. Vital status was ascertained by linkage to the Social Security Administration Death Master File and response to mailings. Participants were followed from the date when their 2004-2005 questionnaire was returned and scanned until the date of first primary cancer diagnosis, death, movement out What's new? Everyone knows that smoking causes cancer. But could it be that indulging in the occasional cigarette does less harm than heavy daily smoking? Sorry, new data say no. Many smokers have been limiting themselves to 10 or fewer smokes per day, and researchers could not say for certain how this "low-intensity" smoking impacts health. Here, the authors calculated cancer risk for adults' age 59-82 participating in the NIH-AARP Diet and Health study. Lifelong low-intensity smokers were 2.34 times as likely as never-smokers to develop smoking-related cancers. Quitting, they found, did reduce cancer risk, even for light smokers. 
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of the registry catchment area, or end of follow-up (December 31, 2011), whichever occurred first. First incident primary cancers were identified via linkage to cancer registries of the eight baseline recruitment states and three additional states (Arizona, Texas, and Nevada) to which participants were the most likely to move during the follow-up period, an approach estimated to ascertain about 90% of incident cancers in the eight baseline recruitment states in a previous validation study. 20 Smoking-related cancers included cancers reported to be associated with tobacco use with sufficient evidence by the IARC and US Surgeon General Report. 3, 4, 21 These cancers defined using International Classification of Diseases for Oncology (ICD-O)-3 include cancers of head & neck [oral cavity and pharynx (C000-C148) and nose and nasal cavity (C300-C301 and C310-C329)], esophagus (C150-159), stomach (C160-C169), colon (CC180-C189 and C260), rectum (C199 and C209), liver (C220), pancreas (C250-C259), lung (C340-C349), uterine cervix (C530-C539), Ovary (mucinous; C569), urinary bladder (C670-679), kidney (C649 and C659), ureter (C669), and acute myeloid leukemia (histology code: 9840, 9861, 9865-9867, 9869, 9871-9874, 9895-9898, 9910-9911, and 9920) (Supporting Information Table S1 ). Because of small case numbers, we combined cancers of oral cavity, pharynx, nose, and nasal cavity as head and neck cancer, and cancers of esophagus and stomach as upper gastrointestinal (UGI) cancer for the analyses of individual smoking-related cancers.
Statistical analysis
We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for all cancer, all smoking-related cancer, and individual smoking-related cancers using Cox proportional hazards regression with age as the underlying time metric. Never cigarette smokers served as the referent group in all analyses. Covariates in the final models were determined based on literature review and included gender, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, Asian/ pacific islander/native American), education (<high school, high school, post high school, some college, college/post graduate), alcohol intake (continuous), familial history of any cancer (yes/no), and ever regular use of pipe or cigar (yes/ no). Missing values in covariates were categorized as "unknown." Including other potential confounders, such as physical activity, had little change on the associations and thus were not included in the final models. A proportional hazards assumption was confirmed by including a crossproduct of the exposure and follow-up time in the model (p 5 0.28).
We performed a sensitivity analysis whereby we excluded those who reported ever regular use of cigar or pipe (16.7%). We also assessed average smoking intensity by dividing cumulative cigarette exposure by duration of smoking. For example, for a participant who reported smoking 1-10 CPD at age 30-39, we assigned 50 cigarette-years (5 CPD times 10 years) for that age-period, and summed cigarette-years from Former smokers who reported smoking consistent number of cigarettes per day when they smoked. We show only former smokers who consistently smoked <1 or 1-10 cigarettes per day. 3 Current smokers whose reported current number of cigarettes smoked per day was different from amounts earlier in their life. We show only those who reported currently smoking <1 or 1-10 cigarettes per day. 4 Percentages for a "unknown" category for categorical variables were considered in calculation but not shown. 5 Mean (standard error) for continuous variables. 6 Assessed in the follow-up questionnaire in 2004-2005. 7 Assessed in the cohort baseline questionnaire in 1995-1996. Cancer Epidemiology all the other age-periods that the participant reported smoking to compute the cumulative cigarette exposure. We then divided it by smoking duration to create average CPD. All analytic tests were performed using SAS version 9.3 (Cary, CA) with statistical significance defined as p-values <0.05 (two-sided).
Results
The average age of the 238,525 participants at baseline was 70.4 years old (range 59-82) with a majority in their 60s (44.7%) or 70s (54.1%). The cohort included 18,233 current smokers (7.6%), 127,121 former smokers (53.3%), and 93,171 never smokers (39.0%). Among ever smokers, 66.6% started smoking before 20 years and 30.0% started in their 20s, and only 3.4% started smoking in their 30s or older. Almost all (99%) current smokers reported smoking for over 30 years with a mean duration of 48 years. Most smokers who reported currently smoking <1 (85.6%) and 1-10 (67.4%) CPD at baseline had smoked more CPD earlier in their lives (Supporting Information Table S2 ). However, 137 and 1,243 reported consistently using <1 and 1-10 CPD over their lifetime. Lifelong consistent smokers of <1 and 1-10 CPD tended to have started smoking at an older age, were more likely to be female, non-Hispanic black, Hispanic, or Asian/pacific islander/native American, and were less likely to have comorbid conditions than other groups of current smokers (Table 1) .
During a mean follow-up of 6.2 years, we identified 33,286 incident cancers including 12,330 that were smokingrelated, such as lung (n 5 3,980), colorectal (n 5 2,515), bladder (n 5 2,098), upper gastrointestinal (n 5 679 including 366 gastric and 313 esophageal), 632 head and neck, 929 kidney, and 900 pancreatic cancers.
CPD among current smokers was positively associated with smoking-related cancer in a dose-dependent manner after adjusting for covariates (Table 2 ). Even smokers of <1 and 1-10 CPD at baseline were at increased risk of incident HR: hazard ratio, CI: confidence interval. 1 Cancer of oral cavity, oropharynx, nasopharynx, hypopharynx, esophagus, stomach, colorectum, liver, pancreas, nasal cavity, paranasal sinuses, larynx, lung, uterine cervix, ovary (mucinous) urinary bladder, kidney, ureter, and acute myeloid leukemia. 2 Adjusted for gender, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, Asian/pacific islander/native American, or unknown), education (< high school, high school, post high school, some college, college/post graduate, or unknown), alcohol intake (continuous), familial history of any cancer (yes, no, or unknown), and ever regular use of pipe or cigar (yes, no, or unknown). Age was used as the underlying time metric. 3 Excluding participants who reported ever using pipes or cigars regularly in the 1995-1996 initial cohort questionnaire.
smoking-related cancer compared to never smokers. After stratification by consistent or varied CPD during the lifetime, consistent lifelong 1-10 CPD smokers had higher risk of smoking-related cancer (HR, 2.34; 95% CI, 1.86-2.93) than never smokers (Fig. 1) . Consistent lifelong smokers of <1 CPD were also at higher risk of smoking-related cancer (HR, 1.89; 95% CI, 0.90-3.96) than never smokers, although the association was not statistically significant. Higher HRs were observed among <1 (2.36, 95% CI, 1.84-3.03) and 1-10 CPD (3.77, 95% CI, 3.33-4.27) smokers at baseline who had varied their CPD over their lifetime. Similar patterns were also observed for overall cancer (Supporting Information Table  S3 ). We observed similar patterns in a sensitivity analysis where we assessed average smoking intensity: cancer risk was higher among current smokers with lifetime average intensity of 1-10 CPD (HR, 2.43, 95% CI, 2.11-2.80) or <1 CPD (HR, 1.87, 95% CI, 0.97-3.60) than never smokers, although the risk estimate for <1 CPD did not reach statistical significance (Supporting Information Table S4 ). Next, we examined smoking cessation. Former smokers who had consistently smoked 1-10 CPD during the years they smoked had higher risk of smoking-related cancer (HR, 1.15; 95% CI, 1.05-1.26) and overall cancer (HR, 1.07; 95% CI, 1.02-1.12) than never-smokers (Table 3 and Supporting  Information Table S5 ), however, these HRs were weaker than those of current smokers who had continued to smoke at this level. HRs were lower among participants who quit long time ago. Among former consistent 1-10 CPD smokers, the HR for developing a smoking-related cancer was 1.04 (95% CI, 0.89-1.21) for those who quit 40 or more years ago and 2.28 (95% CI, 1.68-3.09) for those who quit <10 years ago. Similarly, we observed higher risks among former consistent 1-10 CPD smokers who had smoked for a longer period: HRs were 1.50 (95% CI, 1.17-1.92) for those who had smoked >30 years and 1.02 (95% CI, 0.90-1.15) for those who smoked 10 years. No clear pattern was observed among former consistent <1 CPD smokers, but our case numbers for these analyses were low. Associations persisted when excluding ever-users of other tobacco products (Tables  2 and 3) .
We also examined associations with specific cancer types. For these analyses, we examined <1 and 1-10 CPD together as a single category of low-intensity smokers ( 10 CPD) to maximize case numbers. Even among this combined category, numbers of cases for each cancer type or group were low. Current consistent smokers of 10 CPD had higher risks of lung (HR, 9.65, 95% CI, 6.93-13.43), bladder (HR, 2.22, 95% CI, 1.22-4.05), and pancreatic cancers (HR, 2.03, 95% CI, 1.05-3.95) than never smokers (Table 4) . Risks of lung and bladder cancers among former consistent 10 CPD smokers generally fell with longer time since cessation and shorter duration of smoking. For example, the HR for lung Figure 1 . Hazard ratio (HR) and 95% confidence interval (CI) for incident cancer overall and smoking-related cancer by lifetime consistent and inconsistent smoking intensity among current smokers of < 1 or 1-10 cigarettes per day. The HRs and 95% CIs were adjusted for gender, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, Asian/pacific islander/native American, or unknown), education (< high school, high school, post high school, some college, college/post graduate, or unknown), alcohol intake (continuous), familial history of any cancer (yes, no, or unknown), and ever regular use of pipe or cigar (yes, no, or unknown). Age was used as the underlying time metric. Smoking-related cancers include cancer of oral cavity, oropharynx, nasopharynx, hypopharynx, esophagus, stomach, colorectum, liver, pancreas, nasal cavity, paranasal sinuses, larynx, lung, uterine cervix, ovary (mucinous) urinary bladder, kidney, ureter, and acute myeloid leukemia.
cancer was 6.04 (95% CI, 3.53-10.32) for those who quit <10 years ago and 1.50 (95% CI, 1.08-2.10) for those who quit 40 or more years ago. Despites small number of cases, longer duration of smoking was also associated with higher risks of head and neck cancer and UGI cancer.
Discussion
In our study of over 230,000 older US adults, current lifelong <1 and 1-10 CPD smokers had higher risk of incident cancer than never-smokers, with associations noted for cancers of the lung, bladder, and pancreas. Associations were strongest among current lifelong <1 and 1-10 CPD smokers and attenuated among former smokers, particularly those who quit smoking long time ago.
Cigarette smoking is causally related to at least 20 types of cancer. [3] [4] [5] Nevertheless, previous studies have focused mostly on participants who smoke 10 CPD or more. Just a few studies to date have examined associations of low-intensity smoking with cancer. Results from these studies are generally consistent with our findings, observing higher risk of cancers, such as lung and head and neck cancers, among those who smoked 1-10 CPD. 9, 14, 15 Data on disease risks among nondaily smokers are even more limited. A previous analysis of the national survey data in Finland from 1978 to 1991 HR: hazard ratio, CI: confidence interval. 1 Cancer of oral cavity, oropharynx, nasopharynx, hypopharynx, esophagus, stomach, colorectum, liver, pancreas, nasal cavity, paranasal sinuses, larynx, lung, uterine cervix, ovary (mucinous) urinary bladder, kidney, ureter, and acute myeloid leukemia. 2 Adjusted for gender, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, Asian/pacific islander/native American, or unknown), education (< high school, high school, post high school, some college, college/post graduate, or unknown), alcohol intake (continuous), familial history of any cancer (yes, no, or unknown), and ever regular use of pipe or cigar (yes, no, or unknown). Age was used as the underlying time metric. 3 Excluding participants who reported ever using pipes or cigars regularly in the 1995-1996 initial cohort questionnaire. showed that occasional cigarette smoking was associated with 1.7 times (95% CI, 1.3-2.1) higher risk of lung cancer than never smoking in men. 22 Another study in the European Prospective Investigation into Cancer and Nutrition (EPIC) indicates higher risks of smoking-related cancer (HR, 1.24; 95% CI, 0.80-1.94) and bladder cancer (HR, 1.92; 95% CI, 0.93-3.98) among occasional smokers than never smokers, although the associations were not statistically significant and were limited by small case numbers. 23 It should be noted, however, that these previous studies largely assessed smoking at one point in time and did not assess changes in smoking intensity over the lifetime.
Although the previous literature on low-intensity smoking is relatively limited, several lines of evidence support our findings. Cigarette smoke contains >700 compounds, hundreds of which are known to be harmful. 4 A substantial body of literature has shown that second-hand smoke, containing all of the same carcinogens and toxicants as main-stream cigarette smoke, although at lower doses, 24, 25 is causally related to lung cancer and other diseases. 12 For example, the US Surgeon General's 2006 Report concluded that nonsmokers who had smoking husbands had up to 29% higher risk than those with nonsmoker husbands. 12 Nonsmokers exposed to workplace second-hand smoke were at 22% higher risk of lung cancer than those without workplace second-hand smoke exposure. These results together support that smoking at low-intensity over the lifetime is associated with higher cancer risk.
An important strength of the current study is detailed data on cigarette smoking intensity over the lifespan, which enabled us to distinguish consistent lifelong low-intensity smokers from low-intensity smokers at baseline who had smoked different amounts per day earlier in their life. A large sample size and a prospective study design were key strengths that allowed us to evaluate the risk of incident cancer among long-term consistent low-intensity smokers, although our case numbers in this group were relatively small.
Our study also had several limitations. We relied on participants' recalling their smoking intensity retrospectively; therefore, participants may have underestimated or overestimated their smoking intensity. Yet, self-reported smoking has been shown to have good correlation with biomarkers, such as nicotine and its metabolites, in blood or urine. 26, 27 Methodologic studies have shown high reliability of retrospective assessment of lifetime smoking, such as age when they started smoking and minimum, maximum, and average CPD. 28, 29 Short-term recall of smoking is generally more reliable than long-term recall. However, a previous longitudinal study showed that people reported past CPD with good validity for 20 years earlier (kappa 5 0.63) and fair validity for 32 years earlier (kappa 5 0.36). 30 In the NIH-AARP cohort, we also observed good concordance of recalled smoking after 10 years in the present study (74% concordance among lifelong consistent smokers of 10 or fewer CPD). 18 Despite our large sample size, we were underpowered to Adjusted for gender, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, Asian/pacific islander/native American, or unknown), education (< high school, high school, post high school, some college, college/post graduate, or unknown), alcohol intake (continuous), familial history of any cancer (yes, no, or unknown), and ever regular use of pipe or cigar (yes, no, or unknown). Age was used as the underlying time metric.
estimate associations between lifelong low-intensity smoking and individual cancers. Although results were similar when we examined average smoking over the lifetime. We also lacked detailed information on noncigarette tobacco use. We performed a sensitivity analysis excluding individuals who reported ever use of cigar or pipe in the initial cohort questionnaires (16.7%) and the results did not change considerably. Nonetheless, we lacked detailed information on other tobacco products, and were unable to examine disease risks of lowintensity cigarette smoking in combination with other tobacco products. Future studies are needed to provide these important risk estimates. Our study participants were also mostly white and older. Future studies are needed in different populations, especially among younger age groups as well as racial/ethnic minorities, as low-intensity smoking has been historically more common among racial/ethnic minorities. 31, 32 In conclusion, in our study of older US adults, participants who consistently smoked 10 or fewer CPD over the lifetime had higher risk of developing cancer than never smokers. Furthermore, risks were lower among former smokers of this level, particularly those who quit at a younger age. These findings provide further evidence that even low levels of cigarette smoking cause cancer. All smokers should quit smoking, regardless of how few cigarettes they smoke per day.
